Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: METACLIPSE THERAPEUTICS CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-08-16 to 2022-08-15
Current total value of award: $4148210
Description: EO14042 - DEVELOPMENT OF MEMBRANE ANCHORED CYTOKINES AS NOVEL VACCINE ADJUVANTS FOR THE ELDERLY.